TauroLock™-HEP100
Proven Protection for Catheter Care
TauroLock™-HEP100 is a specialised catheter lock solution designed to prevent infections and maintain catheter patency. Approved for instillation into all central venous catheters (CVCs) and suitable for all vascular access devices (VADs), this product contains taurolidine, 4% citrate, and 100 IU/mL of heparin. Taurolidine provides broad-spectrum antimicrobial protection against gram-positive and gram-negative bacteria, as well as fungi, including resistant strains like MRSA and VRE. Heparin and citrate work together to prevent occlusions ensuring optimal catheter function.
This formulation is an excellent choice for patients who have previously relied on heparin as an anti-occlusive agent. By preventing the formation of bacterial biofilm, TauroLock™-HEP100 effectively safeguards against catheter-related infections. It is particularly recommended for use in CVCs within oncology and parenteral nutrition applications.
More Information
TauroLock™-HEP100
Available in:
3 mL in ampoule, 10 ampoules per pack (TP-03-3)

Key Benefits of TauroLock™-HEP100
Effective Infection Prevention
TauroLock™-HEP100 contains taurolidine, which offers broad-spectrum antimicrobial protection against gram-positive and gram-negative bacteria, as well as fungi, significantly reducing the risk of catheter-related bloodstream infections (CRBSIs).
The systematic application of TauroLock™-HEP100 in critically ill patients reduces the incidence of CBRSI in ICUs.
Maintenance of Catheter Patency
The combination of 4% citrate and 100 IU/mL of heparin works to prevent occlusions by binding calcium and acting as an anticoagulant, ensuring catheter patency and reducing the risk of thrombosis.
Prevention of Biofilm Formation and Eradication
Taurolidine disrupts microbial cell structures, preventing and eradicating biofilm formation on catheter surfaces. This helps maintain catheter function over time, reducing the need for interventions.
Comprehensive Protection
TauroLock™-HEP100 is ideal for use in high-risk settings such as oncology and parenteral nutrition, combining infection prevention and occlusion reduction to improve patient outcomes and catheter longevity.

To explore the full benefits of TauroLock™ -HEP100 and how it can improve patient care, download the product brochure or visit the TauroPharm website for more information.
For a customised product education session or to discuss catheter-related issues, contact Prima MediPharm today. We’re here to offer expert guidance with your questions and help you place your order.